The purpose of this study is to evaluate the safety and efficacy of a novel topical treatment for dry scalp conditions, including dandruff, seborrheic dermatitis, and atopic dermatitis. The study investigates clinical improvements in symptom severity, participant experience with the treatment, and changes in the scalp microbiome before and after use. By studying this treatment, the investigators aim to provide children and adults with a natural, effective option for managing dry scalp conditions.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Efficacy Determined Using the Investigator's Global Assessment (IGA) - Adult
Timeframe: Baseline, 2 weeks (Study Endpoint)
Efficacy Determined Using the Investigator's Global Assessment (IGA) - Child
Timeframe: Baseline, 2 weeks (Study Endpoint)
Efficacy Determined Using the Total Severity Scale (TSS) - Adult
Timeframe: Baseline, 2 weeks (Study Endpoint)
Efficacy Determined Using the Total Severity Scale (TSS) - Child
Timeframe: Baseline, 2 weeks (Study Endpoint)